Oseltamavir Phosphate
Product Images NDC 53002-3387

2 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oseltamavir Phosphate (NDC 53002-3387). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530023387)

Label Image (Lbl530023387)
Label for oseltamivir phosphate 75 mg capsules by RPK Pharmaceuticals, Inc. The package contains 10 capsules with dosing instructions to take 1 capsule twice a day for 5 days or as directed. The label includes storage information, lot number, expiration date, and billing NDC codes.*
FDA Label Image

Str (Oseltamavir Str)

Str (Oseltamavir Str)
Chemical structure of oseltamivir phosphate shown as a molecular diagram with labeled functional groups, including ester, amine, and phosphate groups, highlighting the specific stereochemistry and bonding arrangements of the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.